Cypress Capital Management »

Oncolytics Biotech shares owned by Cypress Capital Management

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Cypress Capital Management from 13F filings

Historical chart of Cypress Capital Management investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Cypress Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Cypress Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $135 100 1.35
2023-09-30 $218 100 2.18
2023-06-30 $260 100 2.60
2023-03-31 $120 100 1.20

More positions owned by Cypress Capital Management

Apple (AAPL)
Ishares Tr 20 Yr Bd Etf (TLT)
First Intst Bancsystem Com Cl A (FIBK)
Spdr Gold Trust Gold Shs (GLD)
Costco Wholesale Corporation (COST)
Kraneshares Tr Quadratic Defla (BNDD)
Vaneck Etf Trust Gold Miners Etf (GDX)
Franco-Nevada Corporation (FNV)
Alps Etf Tr Alerian Mlp (AMLP)
Visa Com Cl A (V)
Sprott Etf Trust Jr Gold Miners E (PHYS)
Lockheed Martin Corporation (LMT)
Universal Health Svcs CL B (UHS)
Agnico (AEM)
J P Morgan Exchange Traded F Equity Premium (JEPI)

View all positions for Cypress Capital Management

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech